Subscribe to our Newsletters !!


    Novartis fixes viewpoint as second-quarter deals, benefit fall

    Swiss drugmaker Novartis reduced its 2020 sales outlook on Tuesday after second quarter earnings and profit fell, as hospitals which stocked up on medicines during the first-quarter on account of this COVID-19 pandemic slowed buys. Net income in the three months through June dropped 4% to $1.9 billion, compared to $2.1 billion in 2019. Earnings